Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study

NCT03225287 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Stopped After careful consideration, UCB has decided to no longer pursue PNH as a potential indication for zilucoplan.

Conditions

Interventions

Sponsor

Ra Pharmaceuticals, Inc.